1. Home
  2. ASTH vs GENB Comparison

ASTH vs GENB Comparison

Compare ASTH & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$37.66

Market Cap

1.9B

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$13.04

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTH
GENB
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ASTH
GENB
Price
$37.66
$13.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$34.86
$23.20
AVG Volume (30 Days)
410.9K
499.4K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$519,907,752.00
N/A
Revenue This Year
$27.38
N/A
Revenue Next Year
$10.78
$16.58
P/E Ratio
$132.17
N/A
Revenue Growth
45.90
N/A
52 Week Low
$18.08
$11.00
52 Week High
$39.93
$16.75

Technical Indicators

Market Signals
Indicator
ASTH
GENB
Relative Strength Index (RSI) 58.29 46.45
Support Level $36.95 $11.63
Resistance Level $39.93 $13.76
Average True Range (ATR) 1.48 1.25
MACD -0.44 -0.23
Stochastic Oscillator 28.39 18.14

Price Performance

Historical Comparison
ASTH
GENB

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: